We have developed a 3d printing technology for tablets that improve the bioavailability of Class II and IV drugs. This 3d printing could help improve bioavailability of drugs in your research pipeline, clinical pipeline or commercial drugs.
Milestones
- Lab tested and developed to be affordable and scalable. Looking for commercial partners to test and implement commercially.